News Focus
News Focus
Followers 3805
Posts 244703
Boards Moderated 0
Alias Born 07/30/2007

Re: cjstocksup post# 9625

Wednesday, 12/05/2012 11:41:21 AM

Wednesday, December 05, 2012 11:41:21 AM

Post# of 130524
AMARANTUS BIOSCIENCES INC(OTC:AMBS) The Company has appointed Amgen Co-Founder Joseph Rubinfeld, PhD to its Corporate Advisory Board. Dr. Rubinfeld will assist management in positioning the Company's development programs for partnering, as well as provide guidance on MANF-based small molecule strategies with his extensive medicinal chemistry background.The Company is a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y